Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF for HBV Prophylaxis Post Liver Transplant
NCT05063071Phase 4Unknown
- Sponsor
- Fudan University
- Start
- Jul 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in hepatitis B (HBV), sponsored by Fudan University. Status: unknown.
02
Drugs
tenofovir alafenamide
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT05063071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05063071.